Organization
University of Cincinnati Cancer Center
4 abstracts
Abstract
A phase 1/2 study of REGN7075 in combination with cemiplimab (cemi) in patients (pts) with advanced solid tumors: Efficacy and safety results.Org: Memorial Sloan Kettering Cancer Center, Division of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, University of Cincinnati Cancer Center, START Midwest, Grand Rapids, MI,
Abstract
Analysis of the fecal metagenome in pelvic radiation survivors with or without chronic gastrointestinal toxicity.Org: University of Cincinnati Cancer Center, Department of Infectious Diseases, University of Cincinnati College of Medicine,
Abstract
Disparities in clinical trial participation: Survey of patients with cancer at an academic medical center.Org: University of Cincinnati College of Medicine, Division of Hematology/Oncology, Department of Medicine, University Of Toledo, University of Cincinnati Cancer Center,
Abstract
Genomic and immune profiling of rare non-squamous sinonasal tumors.Org: Winship Cancer Institute, Emory University School of Medicine, Emory University, Atlanta, GA, USA, Caris Life Sciences, Irving, TX, Department of Otolaryngology Head and Neck Surgery, Emory University Hospital Midtown,